Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"The Lancet. Oncology"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Rimassa%2C+Lorenza%22&type=Person&filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22
/vufind/Search/Results?lookfor=%22Rimassa%2C+Lorenza%22&type=Person&filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22
Search /vufind/Search2/Results?lookfor=%22Rimassa%2C+Lorenza%22&type=Person&filter%5B%5D=journalStr%3A%22The+Lancet.+Oncology%22
PubPharm (10)
1
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma : a multicentre retrospective study
enthalten in:
The Lancet. Oncology
| 2023
von
Zeng, Q.
|
Klein, C.
|
Caruso, S.
| +119
Wird geladen...
2
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01) : a multicentre, single-arm, phase 2b study
enthalten in:
The Lancet. Oncology
| 2023
von
Harding, J.
|
Fan, J.
|
Oh, D.
| +61
Wird geladen...
3
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer : results from the OnCovid registry
enthalten in:
The Lancet. Oncology
| 2023
von
Cortellini, A.
|
Tabernero, J.
|
Mukherjee, U.
| +126
Wird geladen...
4
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312) : a multicentre, open-label, randomised, phase 3 trial
enthalten in:
The Lancet. Oncology
| 2022
von
Kelley, R.
|
Rimassa, L.
|
Cheng, A.
| +19
CommentIn: Lancet Oncol. 2022 Aug;23(8):962-963. - PMID 35798015
Wird geladen...
5
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe : results from the retrospective, multicentre, OnCovid registry study
enthalten in:
The Lancet. Oncology
| 2022
von
Pinato, D.
|
Aguilar-Company, J.
|
Ferrante, D.
| +147
Wird geladen...
6
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study
enthalten in:
The Lancet. Oncology
| 2021
von
Pinato, D.
|
Tabernero, J.
|
Bower, M.
| +130
Wird geladen...
7
Gauging the quality-of-life benefits of immunotherapy in hepatocellular carcinoma
enthalten in:
The Lancet. Oncology
| 2021
von
Personeni, N.
|
Rimassa, L.
CommentOn: Lancet Oncol. 2021 Jul;22(7):991-1001. - PMID 34051880
Wird geladen...
8
Shaping the landscape of immune oncology in hepatocellular carcinoma
enthalten in:
The Lancet. Oncology
| 2018
von
Personeni, N.
|
Rimassa, L.
CommentOn: Lancet Oncol. 2018 Jul;19(7):940-952. - PMID 29875066
Wird geladen...
9
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC) : a final analysis of a phase 3, randomised, placebo-controlled study
enthalten in:
The Lancet. Oncology
| 2018
von
Rimassa, L.
|
Assenat, E.
|
Peck-Radosavljevic, M.
| +27
CommentIn: Lancet Oncol. 2018 May;19(5):591-592. - PMID 29625880
Wird geladen...
10
Tivantinib for second-line treatment of advanced hepatocellular carcinoma : a randomised, placebo-controlled phase 2 study
enthalten in:
The Lancet. Oncology
| 2013
von
Santoro, A.
|
Rimassa, L.
|
Borbath, I.
| +25
CommentIn: Lancet Oncol. 2013 Jan;14(1):7-8. - PMID 23182626
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: The Lancet. Oncology
Medienart
10
Aufsätze
10
E-Artikel
10
E-Ressourcen
Zeitschriftentitel
The Lancet. Oncology
Thema
10
Journal Article
7
Multicenter Study
7
Research Support, Non-U.S. Gov't
3
Antineoplastic Agents
3
Randomized Controlled Trial
2
52CMI0WC3Y
2
9ZOQ3TZI87
2
ARQ 197
2
Antibodies, Monoclonal, Humanized
2
Clinical Trial, Phase II
2
Clinical Trial, Phase III
2
Comment
2
EC 2.7.10.1
2
MET protein, human
2
Protein Kinase Inhibitors
2
Proto-Oncogene Proteins c-met
2
Pyrrolidinones
2
Quinolines
2
Sorafenib
2
atezolizumab
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
7
2020-
3
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
10
Englisch
Haven't found what you're looking for?
Wird geladen...